Comparison of CHOP‐19 and CHOP‐25 for treatment of peripheral nodal B‐cell lymphoma in dogs: A European multicenter retrospective cohort study

• DOI: 10.1111/jvim.17222
• Publication Date: 2024-10-18T12:49:42Z
• Authors: Charles Hawkes; Joanna Morris; Spela Bavcar; Craig Wilkie; Surajit Ray; Charlotte Auquier; Sarah Benjamin; Juan Borrego Massó; Sébastien Bottin; Owen Davies; Isabelle Desmas‐B...; Anat Einhorn; Celia Figueroa‐Go...; Katerina Holenova; Elisavet Kritsota...; Kerry Peak; Katherine Smallwood; Elisabetta Treggiari; Paola Valenti; Miguel Garcia de ...; Quentin Fournier
• Keywords: Prednisolone; Peripheral T-cell lymphoma

Peripheral nodal B-cell lymphomas (PNBCL) represent the most common presentation of in dogs. Multiagent CHOP (C = cyclophosphamide, H hydroxydaunorubicin [Doxorubicin], O Oncovin, P prednisolone)-based chemotherapy protocols have been widely accepted as gold standard 1st-line treatment. CHOP-25 and CHOP-19 are commonly prescribed but never directly compared.